Literature DB >> 20063186

The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.

Corinna E Weckerle1, Timothy B Niewold.   

Abstract

Despite recent progress in the understanding of systemic lupus erythematosus (SLE), the striking 9:1 female to male ratio of disease incidence remains largely unexplained. In addition, peak SLE incidence rates occur during the early reproductive years in women. Studies which illuminate potential causes underlying this sex difference and characteristic onset during the reproductive years have the potential to fundamentally advance our understanding of disease pathogenesis in SLE. Similarly, progress in this area will likely inform human reproductive immunology. Studies of sex hormone function in the immune system are of obvious importance; however, it seems likely that many other types of sex-related genetic and immunological differences will contribute to SLE. In this review, we will focus on recent work in sex-related differences in cytokine pathways and genetics of these pathways as they relate to SLE pathogenesis. It seems quite possible that many of these sex-related differences could be important to reproductive fitness, which may explain the conservation of these immune system features and the observed female predominance of SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20063186      PMCID: PMC2891868          DOI: 10.1007/s12016-009-8192-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  71 in total

1.  Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

Authors:  Ronan J Walsh; Sek Won Kong; Yihong Yao; Bahija Jallal; Peter A Kiener; Jack L Pinkus; Alan H Beggs; Anthony A Amato; Steven A Greenberg
Journal:  Arthritis Rheum       Date:  2007-11

2.  17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells.

Authors:  Mark C Siracusa; Michael G Overstreet; Franck Housseau; Alan L Scott; Sabra L Klein
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  X monosomy in female systemic lupus erythematosus.

Authors:  Pietro Invernizzi; Monica Miozzo; Sabine Oertelt-Prigione; Pier Luigi Meroni; Luca Persani; Carlo Selmi; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Silvia Tabano; Silvia Maitz; Simone Pasini; M Eric Gershwin; Mauro Podda
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

Review 4.  Skewing of X chromosome inactivation in autoimmunity.

Authors:  Pietro Invernizzi; Simone Pasini; Carlo Selmi; Monica Miozzo; Mauro Podda
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

5.  Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects.

Authors:  James Kelley; Martin R Johnson; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg
Journal:  Arthritis Rheum       Date:  2007-10

6.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

Authors:  T B Niewold; J Hua; T J A Lehman; J B Harley; M K Crow
Journal:  Genes Immun       Date:  2007-06-21       Impact factor: 2.676

7.  Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus.

Authors:  Timothy B Niewold; Tania L Rivera; Jill P Buyon; Mary K Crow
Journal:  Arthritis Rheum       Date:  2008-02

8.  Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells.

Authors:  Grant C Hughes; Sunil Thomas; Chang Li; Murali-Krishna Kaja; Edward A Clark
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

9.  Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction.

Authors:  Shizhong Han; Joel M Guthridge; Isaac T W Harley; Andrea L Sestak; Xana Kim-Howard; Kenneth M Kaufman; Bahram Namjou; Harshal Deshmukh; Gail Bruner; Luis R Espinoza; Gary S Gilkeson; John B Harley; Judith A James; Swapan K Nath
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

10.  Common variants within MECP2 confer risk of systemic lupus erythematosus.

Authors:  Amr H Sawalha; Ryan Webb; Shizhong Han; Jennifer A Kelly; Kenneth M Kaufman; Robert P Kimberly; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Gary S Gilkeson; Chan-Bum Choi; R Hal Scofield; Sang-Cheol Bae; Swapan K Nath; John B Harley
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

View more
  88 in total

Review 1.  Interferons in autoimmune and inflammatory diseases: regulation and roles.

Authors:  Divaker Choubey; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.

Authors:  Sandra Agik; Beverly S Franek; Akaash A Kumar; Marissa Kumabe; Tammy O Utset; Rachel A Mikolaitis; Meenakshi Jolly; Timothy B Niewold
Journal:  J Rheumatol       Date:  2011-11-01       Impact factor: 4.666

3.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

4.  Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population.

Authors:  Yu Zhai; Ke Xu; Rui-Xue Leng; Han Cen; Wei Wang; Yan Zhu; Mo Zhou; Chen-Chen Feng; Dong-Qing Ye
Journal:  Inflamm Res       Date:  2013-02-23       Impact factor: 4.575

5.  Medication adherence: a qualitative exploration of the experiences of adolescents with systemic lupus erythematosus.

Authors:  Qiu Er Clarice Tan; Xiaocong Gao; Wei How Darryl Ang; Ying Lau
Journal:  Clin Rheumatol       Date:  2021-02-10       Impact factor: 2.980

6.  Androgen receptor gene and sex-specific Alzheimer's disease.

Authors:  Raffaele Ferrari; Saad Dawoodi; Merrill Raju; Avinash Thumma; Linda S Hynan; Shirin Hejazi Maasumi; Joan S Reisch; Sid O'Bryant; Marjorie Jenkins; Robert Barber; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

7.  Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Wasit Wongtrakul; Patompong Ungprasert
Journal:  Clin Rheumatol       Date:  2020-07-07       Impact factor: 2.980

8.  Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients.

Authors:  Mark A Jensen; Karen C Patterson; Akaash A Kumar; Marissa Kumabe; Beverly S Franek; Timothy B Niewold
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

9.  Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Authors:  Silvia N Kariuki; Beverly S Franek; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Andrew D Skol; Timothy B Niewold
Journal:  J Biomed Biotechnol       Date:  2010-07-04

Review 10.  Interferon alpha in systemic lupus erythematosus.

Authors:  Timothy B Niewold; Daniel N Clark; Rafah Salloum; Brian D Poole
Journal:  J Biomed Biotechnol       Date:  2010-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.